Hotchkis & Wiley Capital Management
OSG

Hotchkis & Wiley Capital Management’s Octave Specialty Group OSG Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio OSG Stock Details OSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-793,500
Closed -$5.63M – 473
2025
Q2 		$5.63M Buy
793,500
+235,820
+42% +$1.76M 0.02% 382
2025
Q1 		$4.88M Sell
557,680
-279,970
-33% -$2.95M 0.02% 387
2024
Q4 		$10.6M Buy
837,650
+92,900
+12% +$1.12M 0.04% 237
2024
Q3 		$8.35M Buy
744,750
+123,360
+20% +$1.44M 0.03% 286
2024
Q2 		$7.97M Buy
621,390
+61,470
+11% +$938K 0.03% 302
2024
Q1 		$8.75M Buy
559,920
+173,390
+45% +$2.73M 0.03% 278
2023
Q4 		$6.37M Sell
386,530
-28,510
-7% -$396K 0.02% 359
2023
Q3 		$5.01M Buy
+415,040
New +$5.58M 0.02% 387
2022
Q3 		– Sell
-762,731
Closed -$8.66M – 515
2022
Q2 		$8.66M Buy
762,731
+143,990
+23% +$1.37M 0.03% 191
2022
Q1 		$6.43M Buy
618,741
+147,724
+31% +$2M 0.02% 299
2021
Q4 		$7.56M Sell
471,017
-12,400
-3% -$195K 0.02% 240
2021
Q3 		$6.92M Sell
483,417
-12,730
-3% -$182K 0.02% 251
2021
Q2 		$7.77M Buy
496,147
+114,230
+30% +$1.84M 0.02% 229
2021
Q1 		$6.39M Buy
381,917
+77,140
+25% +$1.26M 0.02% 267
2020
Q4 		$4.69M Sell
304,777
-3,400
-1% -$50.1K 0.02% 293
2020
Q3 		$3.94M Sell
308,177
-17,650
-5% -$227K 0.02% 239
2020
Q2 		$4.67M Buy
325,827
+540
+0.2% +$7.89K 0.02% 189
2020
Q1 		$4.01M Sell
325,287
-8,340
-2% -$160K 0.02% 203
2019
Q4 		$7.2M Buy
333,627
+24,680
+8% +$506K 0.03% 180
2019
Q3 		$6.04M Sell
308,947
-22,810
-7% -$419K 0.02% 149
2019
Q2 		$5.59M Buy
331,757
+185,230
+126% +$3.16M 0.02% 200
2019
Q1 		$2.65M Buy
146,527
+24,280
+20% +$464K 0.01% 364
2018
Q4 		$2.11M Buy
122,247
+1,938
+2% +$35.6K 0.01% 321
2018
Q3 		$2.46M Buy
120,309
+32,807
+37% +$685K 0.01% 346
2018
Q2 		$1.74M Sell
87,502
-27,369
-24% -$505K 0.01% 361
2018
Q1 		$1.8M Hold
114,871
– – 0.01% 163
2017
Q4 		$1.84M Buy
114,871
+104,182
+975% +$1.6M 0.01% 149
2017
Q3 		$184K Buy
+10,689
New +$197K ﹤0.01% 188

Other funds holding OSG

Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CGIC
Continental General Insurance Company Austin, Texas $480M AUM 101.43% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Hotchkis & Wiley Capital Management's OSG Position: Q3 2025 in Review

Hotchkis & Wiley Capital Management sold out of Octave Specialty Group (OSG) in Q3 2025, closing a stake of 793,500 shares — an estimated $5.63M sold.

Hotchkis & Wiley Capital Management first reported a position in OSG in Q3 2017 and held it in 28 quarters. The position peaked at $10.6M in Q4 2024. 130 funds tracked by Wall St. Rank hold OSG as of Q3 2025.

  • Hotchkis & Wiley Capital Management reported no remaining Octave Specialty Group position as of Q3 2025 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 793,500 Octave Specialty Group shares in Q3 2025, an estimated $5.63M.
  • Hotchkis & Wiley Capital Management first reported a position in Octave Specialty Group in Q3 2017 and held it in 28 quarters.
  • Hotchkis & Wiley Capital Management's Octave Specialty Group position peaked at $10.6M in Q4 2024.
  • 130 funds tracked by Wall St. Rank held Octave Specialty Group as of Q3 2025.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.